Curtis Harwig

1.1k citations

27 papers · 833 indexed · h-index 17

Impact in

Organic Chemistry top 5%
- Click Chemistry and Applications
Pharmaceutical Science top 5%
- Fluorine in Organic Chemistry

Papers in

Virology 4
- HIV Research and Treatment 4
Organic Chemistry 10
- Cyclization and Aryne Chemistry 4
- Synthetic Organic Chemistry Methods 3

Co-authors: David M. Perrin Michael J. Adam Richard Ting Thomas J. Ruth Alex G. Fallis Ulrich auf dem Keller Christopher M. Overall Ying Li
Journals: Tetrahedron Letters (3 papers)Bioorganic & Medicinal Chemistry Letters (3 papers)British Journal of Pharmacology (3 papers)The Journal of Organic Chemistry (3 papers)Journal of the American Chemical Society (2 papers)
Partner nations: Canada United States Belgium

In The Last Decade

Curtis Harwig

24 papers receiving 814 citations

Peers

Countries citing papers authored by Curtis Harwig

Since Specialization

Citations

This map shows the geographic impact of Curtis Harwig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Curtis Harwig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Curtis Harwig more than expected).

Fields of papers citing papers by Curtis Harwig

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Curtis Harwig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Curtis Harwig. The network helps show where Curtis Harwig may publish in the future.

Co-authors

The 25 scholars most cited alongside Curtis Harwig, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Curtis Harwig Line = papers co-authored together Curtis Harwig links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Abstract 1871: Development of pelorol analogues to activate the SHIP1 lipid phosphatase; a novel paradigm to suppress B-cell receptor signaling in human B-cell cancers Cancer Research ·Graham Packham, Kent Michael Kinzer, Beatriz Valle‐Argos, Kongyang Zhu, Hong‐xi Zhang, Freda K. Stevenson, Matthew Carter, Mark S. Cragg, Francesco Forconi, Andrew J. Steele, اسفندیار شکرپور, Curtis Harwig, Georg Lenz, Lloyd Mackenzie, Pavel Klener	2018	0
2	AQX‐1125, small molecule SHIP1 activator inhibits bleomycin‐induced pulmonary fibrosis British Journal of Pharmacology ·اسفندیار شکرپور, Grant R. Stenton, Curtis Harwig, Csaba Szabó, Tiziana Genovese, Rosanna Di Paola, Emanuela Esposito, Salvatore Cuzzocrea, Lloyd Mackenzie	2017	15
3	The effect of the novel SHIP1 activator AQX-1125 on allergen-induced responses in mild to moderate asthma European Respiratory Journal ·Brian Leaker, Brian O’Connor, Peter J. Barnes, Joris Lehnert, David Chernoff, Shulekha Das, Pat Tam, Grant R. Stenton, Curtis Harwig, А.П. Рысев	2013	1
4	Characterization of AQX‐1125, a small‐molecule SHIP1 activator British Journal of Pharmacology ·Grant R. Stenton, Lloyd Mackenzie, Patrick Tam, اسفندیار شکرپور, Curtis Harwig, 和彦小林, Judy Toews, David Chernoff, T GPickering, Csaba Szabó	2012	41
5	AQX-1125, A SHIP1 Activator In Clinical Development For Pulmonary Inflammation: Pharmacokinetics, Metabolism And Tolerability In Healthy Humans Volunteers Patrick Tam, Lloyd Mackenzie, Judy Toews, Grant R. Stenton, Curtis Harwig, 和彦小林, Csaba Szabó, T GPickering, David Chernoff	2012	1
6	Synthesis of SHIP1‐Activating Analogs of the Sponge Meroterpenoid Pelorol European Journal of Organic Chemistry ·Labros G. Meimetis, Matt Nodwell, Lu Yang, Xiaoxia Wang, Meysam Jamali, Curtis Harwig, Grant R. Stenton, Lloyd Mackenzie, T GPickering, Brian O. Patrick, Andrew Ming‐Lum, Christopher J. Ong, Gerald Krystal, Alice Mui, Raymond J. Andersen	2012	33
7	Prospective CCR5 Small Molecule Antagonist Compound Design Using a Combined Mutagenesis/Modeling Approach Journal of the American Chemical Society ·Markus Metz, hamid allahverdipuor, Jean Labrecque, Sanjay Danthi, Jonathan Langille, Curtis Harwig, Wen Yang, Marilyn C. Darkes, Gloria Lau, Jane T. Langworth, Gary Bridger, Dominique Schols, Simon P. Fricker, Renato T. Skerlj	2011	12
8	Design of novel CXCR4 antagonists that are potent inhibitors of T-tropic (X4) HIV-1 replication Bioorganic & Medicinal Chemistry Letters ·Renato T. Skerlj, Gary Bridger, Ernest J. McEachern, Curtis Harwig, Christopher R. Smith, Jaime A. Velázquez, D. R. VEALE, Helen S. Yee, Yu. D. Dmitrienko, Y.W. Lee, Michaela KLOPOTOVÁ, Ian R. Baird, Yongbao Zhu, Sadique Ali Wadho, Wen Yang, Michael Sartori, Dana Huskens, Erik De Clercq, Dominique Schols	2011	17
9	Towards kit-like 18F-labeling of marimastat, a noncovalent inhibitor drug for in vivo PET imaging cancer associated matrix metalloproteases MedChemComm ·Ying Li, Richard Ting, Curtis Harwig, Ulrich auf dem Keller, Caroline L. Bellac, Philipp F. Lange, James A. H. Inkster, Paul Schaffer, Michael J. Adam, Thomas J. Ruth, Christopher M. Overall, David M. Perrin	2011	40
10	Novel Matrix Metalloproteinase Inhibitor [18F]Marimastat-Aryltrifluoroborate as a Probe for In vivo Positron Emission Tomography Imaging in Cancer Cancer Research ·Ulrich auf dem Keller, Caroline L. Bellac, Ying Li, Yuanmei Lou, Philipp F. Lange, Richard Ting, Curtis Harwig, Reinhild Kappelhoff, Shoukat Dedhar, Michael J. Adam, Thomas J. Ruth, François Bénard, David M. Perrin, Christopher M. Overall	2010	69
11	Synthesis and SAR of novel CXCR4 antagonists that are potent inhibitors of T tropic (X4) HIV-1 replication Bioorganic & Medicinal Chemistry Letters ·Renato T. Skerlj, Gary Bridger, Ernest J. McEachern, Curtis Harwig, Christopher R. Smith, Kunyuan Li, D. R. VEALE, Helen S. Yee, Jason Crawford, Yu. D. Dmitrienko, Y.W. Lee, Wen Yang, Yongbao Zhu, 薇薇王, D. V. Sartori, Hüseyin Ezilmez, Dana Huskens, Erik De Clercq, Dominique Schols	2010	30
12	Toward [¹⁸F]-Labeled Aryltrifluoroborate Radiotracers: In Vivo Positron Emission Tomography Imaging of Stable Aryltrifluoroborate Clearance in Mice Journal of the American Chemical Society ·Richard Ting, Curtis Harwig, Ulrich auf dem Keller, Siobhan McCormick, Pamela Austin, Christopher M. Overall, Michael J. Adam, Thomas J. Ruth, David M. Perrin	2008	111
13	AMD070, a CXCR4 Chemokine Receptor Antagonist: Practical Large-Scale Laboratory Synthesis Organic Process Research & Development ·Jason Crawford, Gang Chen, David T. Gauthier, Kunyuan Li, Qiang Zhou, Ian R. Baird, Ernest J. McEachern, Jaime A. Velázquez, Curtis Harwig, 八木擴朗, Renato T. Skerlj, Gary Bridger	2008	29
14	Substituent Effects on Aryltrifluoroborate Solvolysis in Water: Implications for Suzuki−Miyaura Coupling and the Design of Stable ¹⁸F-Labeled Aryltrifluoroborates for Use in PET Imaging The Journal of Organic Chemistry ·Richard Ting, Curtis Harwig, Valentina Ginevičienė, Ying Li, Michael J. Adam, Thomas J. Ruth, David M. Perrin	2008	97
15	A cofactor approach to copper-dependent catalytic antibodies Proceedings of the National Academy of Sciences ·Kenneth M. Nicholas, Paul Wentworth, Curtis Harwig, Anita D. Wentworth, 谭县领, Kim D. Janda	2002	28
16	A one-pot multistep approach to α-azido-phosphonate and phosphonothioate diesters: key intermediates in the synthesis of haptens for the generation of antibody ligases Bioorganic & Medicinal Chemistry Letters ·Curtis Harwig, Timothy Z. Hoffman, Anita D. Wentworth, Kim D. Janda	2000	2
17	Organometallic reagents and protocols for synthesis Polyhedron ·Alex G. Fallis, Pat Forgione, Simon Woo, Stéphanie Legoupy, Sandrine Py, Curtis Harwig, 越赵	2000	2
18	Taxamycin studies: Synthesis of taxoid-calicheamicin hybrids Tetrahedron Letters ·Sandrine Py, Curtis Harwig, Srabani Banerjee, David L. Brown, Alex G. Fallis	1998	21
19	Unexpected 1,3-oxazolidine formation in the attempted oxidation of N-aryl-N-methyl substituted β-amino alcohols using pyridinium dichromate Tetrahedron Letters ·Jari Yli‐Kauhaluoma, Curtis Harwig, Paul Wentworth, Kim D. Janda	1998	19
20	Taxamycins: a new enediyne family with synthetic and biological potential Canadian Journal of Chemistry ·Jiao Wang, Curtis Harwig, Alex G. Fallis	1995	16

About Curtis Harwig

Curtis Harwig is a scholar working on Virology, Organic Chemistry, Radiology, Nuclear Medicine and Imaging, Oncology and Cancer Research, having authored 27 papers that have together received 833 indexed citations. Recurring topics across this work include Chemical Synthesis and Analysis (6 papers), PI3K/AKT/mTOR signaling in cancer (6 papers), HIV Research and Treatment (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Cyclization and Aryne Chemistry (4 papers), Radiopharmaceutical Chemistry and Applications (3 papers), Synthetic Organic Chemistry Methods (3 papers) and Peptidase Inhibition and Analysis (3 papers). The work is most often cited by research in Organic Chemistry (332 citations), Pharmaceutical Science (66 citations), Radiology, Nuclear Medicine and Imaging (243 citations), Virology (45 citations) and Oncology (199 citations). Curtis Harwig has collaborated with scholars based in Canada, United States and Belgium. Frequent co-authors include David M. Perrin, Michael J. Adam, Richard Ting, Thomas J. Ruth, Alex G. Fallis, Ulrich auf dem Keller, Christopher M. Overall, Ying Li, Grant R. Stenton and Lloyd Mackenzie. Their work appears in journals such as Tetrahedron Letters, Bioorganic & Medicinal Chemistry Letters, British Journal of Pharmacology, The Journal of Organic Chemistry and Journal of the American Chemical Society.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact